Venetoclax is under clinical development by AbbVie and currently in Phase II for Aplastic Anemia. According to GlobalData, Phase II drugs for Aplastic Anemia have a 67% phase transition success rate ...

Blood disorders affect millions worldwide—an estimated 5% of the global population suffers from conditions like anemia ... cause excessive bleeding. The causes of blood disorders range from ...

Nearly 35% of regular donors develop iron deficiency. One of the main causes of iron deficiency anemia is blood loss, according to the National Heart, Lung, and Blood Institute (NHLBI).

A 14-year-old patient presented to the ED with a 12-month history of joint pains and a 2-month history of headaches and ...

What causes PNH? How is PNH diagnosed ... recommended or know of clinical trials you haven’t heard of. The Aplastic Anemia and MDS International Foundation offers virtual monthly support ...

Explore how blood transfusions can save lives in anemic heart attack patients, analyzing treatment effects and mortality ...

T-LGLL is caused by pro-inflammatory states, such as rheumatoid arthritis and other autoimmune diseases. T-LGLL causes severe neutropenia, anemia, and in more aggressive presentations, bone marrow ...

Still, the impact of the blood supply shortage on pediatric patient outcomes is poorly documented. Therefore, this study ...

If you have anemia without an established cause, your healthcare provider may pursue further testing to rule out cancer-related causes. Anemia is the medical term for having lower-than-normal levels ...

A recent study showed HDFN caused by irregular antibodies tend to have worse outcomes and prognoses compared to more common ...